TCL Archive FDA Didn’t Punish Duke for Failing To Seek Proper Regulatory Clearance for Three Trials January 27, 2012
TCL Archive NBCC Sees $2.6 billion for Breast Cancer By Year 2000, Begins Voter Registration Drive May 10, 1996
TCL Archive Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival April 25, 2014